Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06558864
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-04
Brief Title:
High Selective Subiculum SEEG Guided RF-TC for mTLE-HS
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Efficacy and Safety of Subiculum Stereotactic-EEG Guided Radio-frequency Thermocoagulation for Mesial Temporal Lobe Epilepsy With Hippocampus Sclerosis A Prospective Single-Arm Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this research is to study the efficacy and safety of Stereotactic EEG SEEG guided radio-frequency thermocoagulation RF-TC of Subiculum as adjunctive therapy for reducing the frequency of seizures in drug-resistant temporal lobe epilepsy with Mesial temporal lobe epilepsy with hippocampal sclerosis mTLE-HS
Detailed Description:
Mesial temporal lobe epilepsy mTLE is the most classical subtype of temporal lobe epilepsy which is the indication of surgical intervention after evaluation This project aims to include 20 participants and evaluate the effectiveness and safety of Stereotactic EEG SEEG guided radio-frequency thermocoagulation RF-TC of Subiculum in patients with mesial temporal lobe epilepsy with hippocampal sclerosis through A prospective interventional unblinded single-arm clinical trial It is expected to provide new therapeutic options for patients with mTLE-HS with alternative treatment options
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None